168 related articles for article (PubMed ID: 11450872)
1. Hypersensitivity syndrome (DRESS) and meningoencephalitis associated with nevirapine therapy.
Lanzafame M; Rovere P; De Checchi G; Trevenzoli M; Turazzini M; Parrinello A
Scand J Infect Dis; 2001; 33(6):475-6. PubMed ID: 11450872
[TBL] [Abstract][Full Text] [Related]
2. DRESS (drug rash with eosinophilia and systemic symptoms) syndrome associated with nevirapine therapy.
Bourezane Y; Salard D; Hoen B; Vandel S; Drobacheff C; Laurent R
Clin Infect Dis; 1998 Nov; 27(5):1321-2. PubMed ID: 9827291
[No Abstract] [Full Text] [Related]
3. Nevirapine-induced rash with eosinophilia and systemic symptoms (DRESS).
Gill S; Sagar A; Shankar S; Nair V
Indian J Pharmacol; 2013; 45(4):401-2. PubMed ID: 24014920
[TBL] [Abstract][Full Text] [Related]
4. Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection.
Santos RP; Ramilo O; Barton T
Pediatr Infect Dis J; 2007 Nov; 26(11):1053-6. PubMed ID: 17984815
[TBL] [Abstract][Full Text] [Related]
5. [Cutaneous, hepatic and hematologic manifestations due to nevirapine: DRESS syndrome?].
Sissoko D; Ajana F; de la Tribonnière X; Baclet V; Mouton Y
Presse Med; 2000 May 27-Jun 3; 29(19):1041-2. PubMed ID: 10874910
[TBL] [Abstract][Full Text] [Related]
6. Case reports: treatment of nevirapine-associated dress syndrome with intravenous immune globulin (IVIG).
Fields KS; Petersen MJ; Chiao E; Tristani-Firouzi P
J Drugs Dermatol; 2005; 4(4):510-3. PubMed ID: 16004028
[TBL] [Abstract][Full Text] [Related]
7. Drug rash with eosinophilia and systemic symptoms syndrome and renal toxicity with a nevirapine-containing regimen in a pregnant patient with human immunodeficiency virus.
Knudtson E; Para M; Boswell H; Fan-Havard P
Obstet Gynecol; 2003 May; 101(5 Pt 2):1094-7. PubMed ID: 12738113
[TBL] [Abstract][Full Text] [Related]
8. [Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV].
Bayonne Kombo ES; Gathse A
Med Mal Infect; 2013 Mar; 43(3):134-5. PubMed ID: 23434355
[No Abstract] [Full Text] [Related]
9. DRESS syndrome associated with nevirapine therapy.
Claudio GA; Martin AF; de Dios Perrino S; Velasco AA
Arch Intern Med; 2001 Nov; 161(20):2501-2. PubMed ID: 11700164
[No Abstract] [Full Text] [Related]
10. Drug rash with eosinophilia and systemic symptoms (DRESS syndrome).
Tas S; Simonart T
Acta Clin Belg; 1999 Aug; 54(4):197-200. PubMed ID: 10544509
[TBL] [Abstract][Full Text] [Related]
11. Rash and hepatitis within days of starting a new antiretroviral regimen: nevirapine hypersensitivity, secondary syphilis or both?
Saxon CJ; Helbert MR; Komolafe AJ; Higgins SP
Int J STD AIDS; 2014 Mar; 25(3):228-30. PubMed ID: 23970648
[TBL] [Abstract][Full Text] [Related]
12. Is there cross-toxicity between nevirapine and efavirenz in subjects developing rash?
Soriano V; Dona C; Barreiro P; González-Lahoz J
AIDS; 2000 Jul; 14(11):1672-3. PubMed ID: 10983663
[No Abstract] [Full Text] [Related]
13. Autoimmune Limbic Encephalitis and Syndrome of Inappropriate Antidiuretic Hormone Secretion Associated with Lamotrigine-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome.
Ozisik L; Tanriover MD; Saka E
Intern Med; 2016; 55(10):1393-6. PubMed ID: 27181555
[TBL] [Abstract][Full Text] [Related]
14. First report of lamotrigine-induced drug rash with eosinophilia and systemic symptoms syndrome with pancreatitis.
Roquin G; Peres M; Lerolle N; Dib N; Mercat A; Croue A; Augusto JF
Ann Pharmacother; 2010 Dec; 44(12):1998-2000. PubMed ID: 21098750
[TBL] [Abstract][Full Text] [Related]
15. Nevirapine-associated rash in a Jamaican child with HIV/AIDS.
Steel-Duncan JC; Pierre R; Gabay L; Christie CD
West Indian Med J; 2004 Oct; 53(5):356-8. PubMed ID: 15675504
[TBL] [Abstract][Full Text] [Related]
16. Sex differences in nevirapine rash.
Bersoff-Matcha SJ; Miller WC; Aberg JA; van Der Horst C; Hamrick HJ; Powderly WG; Mundy LM
Clin Infect Dis; 2001 Jan; 32(1):124-9. PubMed ID: 11118391
[TBL] [Abstract][Full Text] [Related]
17. Risk factors associated with DRESS syndrome produced by aromatic and non-aromatic antipiletic drugs.
Pereira de Silva N; Piquioni P; Kochen S; Saidon P
Eur J Clin Pharmacol; 2011 May; 67(5):463-70. PubMed ID: 21359537
[TBL] [Abstract][Full Text] [Related]
18. [Drug reaction with eosinophilia and systemic symptoms (DRESS)].
Descamps V
Rev Prat; 2012 Dec; 62(10):1347-52. PubMed ID: 23424909
[TBL] [Abstract][Full Text] [Related]
19. Six-year retrospective review of drug reaction with eosinophilia and systemic symptoms.
Wongkitisophon P; Chanprapaph K; Rattanakaemakorn P; Vachiramon V
Acta Derm Venereol; 2012 Mar; 92(2):200-5. PubMed ID: 22002792
[TBL] [Abstract][Full Text] [Related]
20. DRESS syndrome associated with raltegravir.
Zhang KS; Modi GM; Hsu S
Dermatol Online J; 2011 Aug; 17(8):14. PubMed ID: 21906494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
